PARP Inhibitors in Prostate Cancer- Who, When, and Why (not)

PARP Inhibitors in Prostate Cancer- Who, When, and Why (not)

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Ravi A. Madan, MD

Date of Release

May 14th, 2025